J&J, Bristol Myers lose challenges to drug price negotiation program

By Reuters
| April 30, 2024

A fourth federal judge upholds the program, one of President Joe Biden's signature initiatives, against drug industry challenges, rejecting their argument that it was an illegal taking of their property.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...